Clinical Trials

The purpose of this study is to identify brain imaging and clinical feature biomarkers using machine-learning algorithms that distinguish individuals at high risk for developing persistent post-trauma headache (PPTH) from patients who are likely to acutely recover from PTH prior to three months.

The purpose of this study is to better understand the issues of patient discomfort after a lumbar puncture.

The purpose of this study is to analyze the effectiveness of the sphenopalatine ganglion (SPG) block with lidocaine vs. SPG block with placebo in preventing the need for epidural blood patch (EBP) in women who develop post dural puncture headache (PDPH) after accidental puncture during placement of lumbar epidural anesthesia (LEA) for labor.

The purpose of this study is to identify mechanisms and predictors for the persistence of post-traumatic headache and methods to treat post-traumatic headache and prevent its persistence. This study will address individual projects not covered by IRB 19-003200 and is done at the request of the DOD.

This study is designed to answer the question of whether injection of the greater occipital nerve at its proximal origin, near the C2 vertebrae, using ultrasound guidance is effective in improving pain in human subjects.

HYPOTHESES

1. Ultrasound (US) guided greater occipital nerve (GON) injections are effective at a novel, proximal C2 location in live, human subjects, measured by improvement in visual analog scale (VAS) pain scores pre-injection compared to VAS scores 30 minutes post-injection, 2-weeks post-injection, and 1-month post-injection.
2. Ultrasound (US) guided injection of the greater occipital nerve (GON) at a novel, C2 location is effective at improvement of both occipital neuralgia and ...

The purpose of this study is to evaluate Neostigmine and Glycopyrrolate to treat post-dural puncture headache (PDPH) to reduce the proportion of postpartum women with a PDPH requiring EBP who developed a PDPH after accidental dural puncture with a Tuohy needle.

The primary objective of the study is to demonstrate the safety and efficacy of SPG stimulation with the ATI Neurostimulation System when used to treat acute cluster attacks in chronic cluster headache patients.

The purpose of this study is to investigate the use of rimegepant for the treatment of cluster headache. 

The main purpose of this study is to evaluate the effectiveness and safety of the study drug known as LY2951742 for the treatment of patients who have episodic cluster headaches.

The purpose of this study is to evaluate treatment effects, including safety, and is intended to show a statistically significant effect on number of attacks during the cluster headache bout.

The purpose of this study is to predict migraine headache onset from changes in speech in people who have a history of migraines.  

The main purpose of this study is to assess the long-term safety and tolerability of galcanezumab administered up to once monthly in participants with episodic or chronic cluster headache who have completed study I5Q-MC-CGAL (NCT02397473) or study I5Q-MC-CGAM (NCT02438826).

The purpose of this study is to use structural and functional neuroimaging to compare what regional brain changes are similar or distinctly different between migraines and TAC ( trigeminal autonomic cephalagias).

The purpose of this study is to find sex-based differences in migraine-related functional connectivity. To achieve this, men with migraine will be compared to men healthy controls and women with migraine will be compared to women healthy controls.

Men and women with migraine will then be compared, using region-pairs that differed in the single-sex comparisons.  Identification of migraine-related, sex-specific, functional imaging aberrations will provide insights into sex-specific migraine pathophysiology and will inform future imaging studies

The purpose of this study is to determine how frequently primary headache syndromes occur in a population of epilepsy patients admitted to an epilepsy monitoring unit.

The purposes of this study are to evaluate the response of hemicrania continua to treatment with erenumab, and to evaluate the safety and tolerability of erenumab in patients with hemicrania continua.

The primary purpose of this study is to demonstrate the safety and effectiveness of sphenopalatine ganglion stimulation with the Autonomic Technologies, Inc. Neurostimulation System when used to treat acute cluster attacks in chronic cluster headache patients.

The purpose of this study is to assess the safety, tolerability, and optimal dose of the COOLSTAT Transnasal Thermal Regulating Device for acute treatment of migraine. The hypothesis is that evaporative cooling induced by the CoolStat using only ambient, dry air will reduce the pain and other symptoms of migraine headaches during an acute migraine episode.

The main purpose of this study is to evaluate the efficacy of the study drug known as LY2951742 in participants with chronic cluster headache.

A study to test if Fremanezumab reduces headache in patients with Posttraumatic Headache (PTH)

The purpose of this study is to evaluate the long-term safety of Fremanezumab in all patients with migraine through evaluation of incidence of all adverse events.

This study will compare the analgesic benefit of a traditional landmark-guided GON block with the ultrasound-guided approach over a four week period in patients with occipital neuralgia or cervicogenic headache.

The main purpose of this extended study is to evaluate the long term effectiveness of the study drug LY2951742 in patients who have chronic cluster headaches.

The purpose of this study is to collect additional data on the safety and effiectiveness of the SPRINT PNS System for the treatment of head pain due to cervicogenic headache or occipital neuralgia.

The purpose of this study is to assess ALD403 in the prevention of migraine headache in chronic migraineurs.

This study is utilizing the Mayo Clinic Cures at Home participation services. For questions regarding home research services in this study please reach out to curesathome@mayo.edu.

The purpose of this study is to investigate facial pain improvement with twice-daily use of a novel device combing acoustic vibration with oscillating expiratory pressure compared with a sham device in male and female participants > 18 years of age with sinus pain/headache lacking objective evidence of sinonasal inflammation.

The study sponsor has developed a non-invasive treatment for reducing migraine pain. The Theranova Migraine Treatment System uses electrical stimulation applied to the skin.

The purpose of this study is to create individualized prediction models utilizing sensor data and cognitive function which will accurately identify the premonitory phase of the migraine attack and predict an oncoming migraine headache.

This study will seek to determine which measures differ between migraine attack phases (e.g., interictal vs. premonitory), develop an initial migraine prediction algorithm, and to provide insights into how long prior to headache onset premonitory changes begin. It will also look for migraine phenotypes associated with changes in sensor-measured data during the preictal vs. ictal or interictal periods.

This study will evaluate the long-term safety and tolerability of intermittent treatment with ubrogepant for the acute treatment of migraine over 1 year.

This study will assess the efficacy of a neuromodulation device for the treatment of episodic migraine headache.

The purpose of this study is to test the accuracy of a previously developed algorithm for predicting patient outcomes to migraine preventive treatments. Also, to optimize the performance of a previously developed algorithm for predicting patient outcomes to migraine preventive treatments.

The purpose of this study is to investigate the use of erenumab 140mg IV in patients with status migrainosus. The specific aims of the study are to evaluate early endpoints of response including pain freedom at 2 hours, absence of the most bothersome symptom (MBS) at 2 hours, change in pain severity at 2 hours, and sustained pain freedom at 24 hours, and to evaluate late endpoints of response including change in migraine days at 4 weeks compared to baseline report, change in headache days at 4 weeks compared to baseline report, and change in acute medication use.

The purpose of this study is to accurately track biomarkers of headache coupled with patient reporting of severity with minimal effort by the patient using a custom phone app integrating patient and devices. Also, to accurately forecast periods of increased headache likelihood to allow patients earlier and more effective treatments.

The purpose of this study is to enroll in a registry patients who have headache disorders, collecting detailed headache characteristics, biospecimens, and brain imaging data, to allow for more research into accurate diagnosis, prognosis, and treatments.

This research study is being done to help determine if King-Devick test (KDT) and Visual Contrast Sensitivity (VCS) can detect migraine-induced cerebral function changes.

Changes in vision are commonly reported by patients during migraine attacks. Even in patients that do not report changes in vision, we have noted objective changes as demonstrated by changes in the King-Devick Test (KDT), a quantitative measure of rapid eye movement; which was 6.5 seconds slower (SD 7.6 seconds, p<0.001) during a migraine attack compared to between migraine attacks. this study aims to evaluate changes in timed rapid number naming using the kdt during the twelve hours prior to a migraine attack (“pre-attack” phase) and during the migraine attack compared to the between attack phase. accurate prediction of an ... during="" a="" migraine="" attack="" compared="" to="" between="" migraine="" attacks.="" this="" study="" aims="" to="" evaluate="" changes="" in="" timed="" rapid="" number="" naming="" using="" the="" kdt="" during="" the="" twelve="" hours="" prior="" to="" a="" migraine="" attack="" (“pre-attack”="" phase)="" and="" during="" the="" migraine="" attack="" compared="" to="" the="" between="" attack="" phase.="" accurate="" prediction="" of="" an="" ...="">

The purpose of this study is to see how much gabapentin will reduce headaches associated with subarachnoid hemorrhage (SAH) and to reduce the amount of narcotic pain medication prescribed.

The purpose of this study is to identify changes in brain function and structure that correlate with response to erenumab, and to develop models using imaging data to predict which patients will respond to erenumab.

The purpose of this study is to investigate the accuracy of predicting migraine attacks in individual patients using a mobile phone app and a Fitbit  to collect daily headache diary data, exposure/trigger data and physiologic data. It is believed the data will predict the occurrence of migraine attacks with high accuracy via the mobile phone app.

This study will evaluate the efficacy, safety, and tolerability of 2 doses of ubrogepant (25 and 50 mg) compared to placebo for the acute treatment of a single migraine attack.

The purpose of this study is to determine the feasibility of using SSPGB to reduce the self-reported headache pain that patients with aneurysmal SAH experience during their hospital admission.

The purpose of this study is to prospectively determine what method of assessment predicts headache directionality using three standardized methods: 1) pictorial representation, 2) standardized patient survey and 3) standardized headache neurology investigator assessment.

The purpose of this study is to assess the efficacy and safety of ALD403 in the prevention of migraine headache in chronic migraineurs.

The purpose of this study is to identify whether there is a difference in prolactin levels between patients with chronic migraine and healthy controls. This may help to explain the sensitivity to pain those patients with chronic migraine experience and may also help to establish a target for new treatments of chronic migraine

The purpose of this study is to compare eye glass lenses that have been treated with tints, to lenses that have been treated with thin-films to reduce light sensitivity and headache in patients who have chronic migraine. It is unknown if there is an advantage to either spectacle lens treatment. Both treatments could be a novel, non-invasive addition in the treatment of chronic migraine.

The primary purpose of this study is determine the frequency of positive visual symptoms including visual snow in pediatric patients seen for general pediatric care as well as for neurologic care.  

The secondary purpose is to determine if positive visual symptoms are more common in pediatric patients who also have a self-reported history of headache or migraine.  

The purpose of this study is to study the length of the QTc interval in patients receiving the standard of care dose of intravenous droperidol for headache or migraine, nausea, pain, and indications other than agitation over 30 minutes.

Headache is the most commonly reported symptom after trauma to the head. Although posttraumatic headache (PTH) shares some clinical characteristics with primary headache disorders, such as migraine, there are many unique features including head trauma and the exacerbation of headache with physical and cognitive stressors. The purpose of this study is to determine if subjects who have recently sustained a mild TBI and have PTH will have lower pain thresholds (i.e. hyperalgesia) and greater allodynia compared to healthy controls. The study will also determine if exposure to a bright light stressor will exacerbate hyperalgesia in subjects with mild TBI and PTH ...

The purpose of this research study is to test two medicines for migraine prevention in children and adolescents. The investigators want to see if amitriptyline and/or topiramate are better than placebo (sugar pill) in reducing headache frequency in children and adolescents ages 8 to 17 with migraines. At this time, there are no FDA approved medicines approved in the US for the prevention treatment of migraine headaches in children and adolescents.

The purpose of this study is to evaluate Patent Foramen Ovale (PFO) closure for migraine headache relief using the GORE® CARDIOFORM Septal Occluder after a trial of oral anticoagulation therapy vs. placebo for a 6 week period.

The purpose of this research study is to test two medicines for migraine prevention in children and adolescents. The investigators want to see if amitriptyline and/or topiramate are better than placebo (sugar pill) in reducing headache frequency in children and adolescents ages 8 to 17 with migraines. At this time, there are no FDA approved medicines approved in the US for the prevention treatment of migraine headaches in children and adolescents.

The purpose of this study is to identify mechanisms and predictors for the persistence of post-traumatic headache and methods to treat post-traumatic headache and prevent its persistence.